☆ 4.7 Article

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy

Yao Liu et al.

Summary: By combining spatial transcriptomics with single-cell RNA sequencing and multiplexed immunofluorescence, we identified a tumor immune barrier (TIB) structure composed of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) that is associated with the efficacy of immunotherapy. Disrupting the TIB structure may be a relevant therapeutic approach to enhance the therapeutic effect of immune checkpoint blockade in HCC.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Review Oncology

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally. Traditional treatments involve specific drugs, but the emergence of immune checkpoint inhibitors has revolutionized the management of HCC.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

Claudia D. Fuchs et al.

Summary: Bile acids play a crucial role in regulating metabolism and homeostasis, and their disrupted balance can contribute to gastrointestinal and liver diseases. Targeting bile acid pathways may provide novel treatment strategies for these disorders.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Article Oncology

Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy

Jiawei Shi et al.

Summary: The study highlighted the importance of immune signatures in early detection and immunotherapy efficacy assessment for patients with HCC, utilizing a single-cell approach to identify stage-specific immune signatures and constructing a classifier for early prediction of HCC.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Article Oncology

Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma

Lulu Liu et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), accounts for 6% of cancer-related deaths globally, with unclear understanding of how the tumor microenvironment contributes to HCC progression. Through multiomics analysis, this study identified SPP1 as an immune-related predictor of poor survival in HCC patients, mediating the crosstalk between HCC cells and macrophages. In vitro experiments confirmed that SPP1 can drive the polarization of macrophages to M2-phenotype tumor-associated macrophages (TAMs).

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The role of bile acids in carcinogenesis

Tadeja Rezen et al.

Summary: Bile acids are soluble derivatives of cholesterol produced in the liver that undergo bacterial transformation to yield various metabolites. Most bile acid synthesis occurs in the liver, but other tissues, such as the ovaries, can also generate bile acids. After synthesis, hepatic bile acids are transported to bile and released into the intestines. In the large intestine, primary bile acids are converted to secondary bile acids by gut bacteria. The majority of intestinal bile acids are reabsorbed and return to the liver, while a small fraction remains in circulation and has effects on cancer cells. This review discusses the involvement of bile acids in various cancers and emphasizes the importance of using physiologically relevant concentrations of bile acids in research.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Article Medicine, General & Internal

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

Changfa Xia et al.

Summary: The study compared the latest cancer profiles, trends, and determinants between China and the USA in 2022. China has a higher incidence of lung cancer, while the USA has more cases of breast cancer. Recent years have seen a significant decrease in lung and colorectal cancer rates in the USA, while liver cancer rates have slightly increased. In China, rates for stomach, liver, and esophageal cancer have decreased gradually, but colorectal cancer rates have increased for the whole population.

CHINESE MEDICAL JOURNAL (2022)

Add to Collection

Review Gastroenterology & Hepatology

Emerging immunotherapy or HCC: A guide for hepatologists

Friedrich Foerster et al.

Summary: HCC is one of the most common and deadliest cancers globally. Immuno-oncology has shown promising results in the treatment of HCC, with immune checkpoint inhibition becoming the first-line therapy for advanced cases. However, challenges remain in determining the role of immunotherapy in earlier stages of HCC and identifying treatment strategies for non-responsive patients.

HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis

Renqiang Sun et al.

Summary: This study uncovers a new function of SIRT5 in regulating bile acid metabolism to prevent tumor immune evasion and suppress HCC development.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Maria Reig et al.

Summary: There have been significant advances in the treatment strategies for hepatocellular carcinoma since the last update in 2018. However, some interventions still lack sufficient data for clinical incorporation, and personalized clinical management requires consideration of multiple parameters.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)

Z. Wang et al.

Summary: This study identified novel genes associated with fibrosis progression in nonalcoholic steatohepatitis (NASH) and explored their effects on fibrosis from a single-cell perspective. The findings may provide new insights for the early diagnosis, monitoring, evaluation, and prediction of fibrosis progression in NASH.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Add to Collection

Article Biochemical Research Methods

Immune infiltration and clinical significance analyses of the coagulation-related genes in hepatocellular carcinoma

Qifan He et al.

Summary: In this study, the correlation between coagulation and hepatocellular carcinoma (HCC) was investigated. It was found that coagulation is related to the tumor immune microenvironment (TME) of HCC. A coagulation-related risk score prognostic model was developed to predict the risk and prognosis of HCC patients. This model may have therapeutic benefits for chemotherapy and immunotherapy and can aid in clinical decision making.

BRIEFINGS IN BIOINFORMATICS (2022)

Add to Collection

Article Immunology

Endoplasmic Reticulum Stress-Related Signature for Predicting Prognosis and Immune Features in Hepatocellular Carcinoma

Genhao Zhang et al.

Summary: This study constructed a novel four-gene risk model based on endoplasmic reticulum stress-related genes (ERSRGs), which accurately predicts survival outcomes in hepatocellular carcinoma (HCC) patients and is associated with clinical classification.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Add to Collection

Article Oncology

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes

Chen Xue et al.

Summary: Based on the analysis of genes related to tryptophan metabolism, we identified two metabolic phenotypes and established a risk model that can be used to predict the prognosis and guide immunotherapy in patients with hepatocellular carcinoma.

CANCER CELL INTERNATIONAL (2022)

Add to Collection

Article Gastroenterology & Hepatology

Melanoma differentiation associated gene-9/syndecan binding protein promotes hepatocellular carcinoma

Debashri Manna et al.

Summary: This study investigated the role of MDA-9 in hepatocellular carcinoma (HCC) by generating a transgenic mouse model with hepatocyte-specific overexpression of MDA-9. The study found that high expression of MDA-9 was associated with activation of NF-kappa B and Spp1, promoting HCC development. These results support the potential use of MDA-9 inhibitors as a treatment for aggressive HCC.

HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Global burden of primary liver cancer in 2020 and predictions to 2040

Harriet Rumgay et al.

Summary: The burden of liver cancer varies across the world, and it is a major cause of death in many countries. The number of liver cancer cases and deaths is predicted to increase, with a significant rise expected by 2040.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Metabolic Messengers: bile acids

Alessia Perino et al.

Summary: Bile acids are amphipathic steroid acids that play a crucial role in the regulation of metabolic responses. Their actions through activation of specific receptors control energy homeostasis and alterations in bile acid signaling are associated with metabolic diseases. Modulation of the bile acid pool could be a potential therapeutic approach.

NATURE METABOLISM (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis

Xiaoming Liu et al.

Summary: Recent studies have highlighted the crucial role of aberrant regulatory interactions in driving malignant phenotypes of hepatocellular carcinoma (HCC) cells. Specifically, the long noncoding RNA DLX6-AS1 was shown to promote HCC progression by modulating the miR-513c/Cul4A/ANXA10 axis, affecting cell viability, migration, invasion, and apoptosis. Silencing DLX6-AS1 could inhibit HCC development and provide potential therapeutic targets for HCC treatment.

CANCER GENE THERAPY (2021)

Add to Collection

Review Cell Biology

Targeting the alternative bile acid synthetic pathway for metabolic diseases

Wei Jia et al.

Summary: The gut microbiota plays a significant role in glucose and lipid metabolism by regulating bile acid metabolism and affecting multiple signaling pathways. Bile acids are synthesized in the liver through two distinct pathways, influencing cholesterol and lipid catabolism and activating various signaling pathways. Modulating bile acid synthesis and composition could be a novel approach for developing therapies for metabolic diseases.

PROTEIN & CELL (2021)

Add to Collection

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Article Oncology

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

Honglei Feng et al.

Summary: The study found that PIVKA-II is a promising biomarker for HCC diagnosis, with remarkable diagnostic performance as an individual biomarker, and its combination with AFP can significantly improve the diagnostic efficiency of HCC. There were significant correlations between PIVKA-II expression levels and certain clinicopathological characteristics, and PIVKA-II can be used to evaluate the curative effects of surgical treatment for HCC.

BMC CANCER (2021)

Add to Collection

Review Gastroenterology & Hepatology

Advances in immunotherapy for hepatocellular carcinoma

Bruno Sangro et al.

Summary: Immunotherapeutic interventions have shown effectiveness in the treatment of hepatocellular carcinoma. Checkpoint inhibitors have demonstrated strong anti-tumor activity, but other immune strategies have not yet shown consistent clinical activity. Advancing treatment to earlier stages, discovering predictive biomarkers, and exploring effective combinatorial approaches are key challenges in HCC immunotherapy.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transition (EMT) Induced by TGF-beta in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism

Jitka Soukupova et al.

Summary: EMT induced by TGF-beta in HCC cells reprograms lipid metabolism to facilitate the utilization of FFA and the entry of acetyl-CoA into the TCA cycle, to sustain the elevated requirements of energy linked to this process.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Microbiology

Review: microbial transformations of human bile acids

Douglas V. Guzior et al.

Summary: Bile acids play key roles in gut metabolism, cell signaling, and microbiome composition. Microbes in the gut modify primary bile acids into diverse forms, and alterations in these secondary bile acids have been linked to various diseases. Recent studies have shown that gut microbiota can conjugate amino acids to bile acids, greatly increasing the diversity of bile acids in mammalian gut.

MICROBIOME (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression

Chen Xue et al.

Summary: Circular RNAs (circRNAs) are covalently closed noncoding RNAs that regulate target gene expression and play important roles in cancer progression through the circRNA/PI3K/AKT axis. Aberrant regulation of circRNA expression is significantly associated with clinicopathological characteristics and plays crucial roles in biological functions.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Oncology

Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer

Jian Carrot-Zhang et al.

CANCER CELL (2020)

Add to Collection

Review Oncology

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy

Chongxian Pan et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Add to Collection

Review Immunology

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Yuanyuan Zhang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver

Anneleen Remmerie et al.

IMMUNITY (2020)

Add to Collection

Article Oncology

Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma

Phuong Thao Nguyen et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma

Antoine L'Hermitte et al.

HEPATOLOGY (2019)

Add to Collection

Article Cell Biology

FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis

Suyuan Ji et al.

DEVELOPMENTAL CELL (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Delivery technologies for cancer immunotherapy

Rachel S. Riley et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection

Article Multidisciplinary Sciences

Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells

Chi Ma et al.

SCIENCE (2018)

Add to Collection

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

Add to Collection

Article Genetics & Heredity

HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas

Qiuyu Lian et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2018)

Add to Collection

Article Oncology

Classification of triple-negative breast cancers based on Immunogenomic profiling

Yin He et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Add to Collection

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

Add to Collection

Article Gastroenterology & Hepatology

The Role of the Gut Microbiota in Bile Acid Metabolism

Oscar Ramirez-Perez et al.

ANNALS OF HEPATOLOGY (2017)

Add to Collection

Article Surgery

Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma

S. -L. Yang et al.

BRITISH JOURNAL OF SURGERY (2016)

Add to Collection

Article Oncology

Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma

Ke Li et al.

CANCER RESEARCH (2016)

Add to Collection

Review Cell Biology

Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism

Annika Wahlstrom et al.

CELL METABOLISM (2016)

Add to Collection

Article Biochemical Research Methods

Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results

Mumtahena Rahman et al.

BIOINFORMATICS (2015)

Add to Collection

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Add to Collection

Review Gastroenterology & Hepatology

Bile acid transporters and regulatory nuclear receptors in the liver and beyond

Emina Halilbasic et al.

JOURNAL OF HEPATOLOGY (2013)

Add to Collection

Article Biochemistry & Molecular Biology

NCBI GEO: archive for functional genomics data sets-update

Tanya Barrett et al.

NUCLEIC ACIDS RESEARCH (2013)

Add to Collection

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Add to Collection

Article Physiology

Bile Formation and Secretion

James L. Boyer

COMPREHENSIVE PHYSIOLOGY (2013)

Add to Collection

Review Toxicology

Carcinogenicity of deoxycholate, a secondary bile acid

Carol Bernstein et al.

ARCHIVES OF TOXICOLOGY (2011)

Add to Collection

Article Biochemical Research Methods

Molecular signatures database (MSigDB) 3.0

Arthur Liberzon et al.

BIOINFORMATICS (2011)

Add to Collection

Review Biochemistry & Molecular Biology

Osteopontin in macrophage function

Susan R. Rittling

EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)

Add to Collection

Article Gastroenterology & Hepatology

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

Kentaroh Yamamoto et al.

JOURNAL OF GASTROENTEROLOGY (2010)

Add to Collection

Article Multidisciplinary Sciences

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie et al.

NATURE (2009)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Bile acids as endogenous etiologic agents in gastrointestinal cancer

Harris Bernstein et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Add to Collection

Article Oncology

Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma

Koji Fukase et al.

CANCER SCIENCE (2008)

Add to Collection

Article Medicine, General & Internal

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

Yujin Hoshida et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection

Article Public, Environmental & Occupational Health

SPP1 polymorphisms associated with HBV clearance and HCC occurrence

Hyoung Doo Shin et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2007)

Add to Collection

Review Gastroenterology & Hepatology

Biliary secretion and excretion in health and disease: Current concepts

Alan F. Hofmann

ANNALS OF HEPATOLOGY (2007)

Add to Collection

Article Gastroenterology & Hepatology

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma

JA Marrero et al.

JOURNAL OF HEPATOLOGY (2005)

Add to Collection

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Add to Collection

Article Gastroenterology & Hepatology

Hepatobiliary transporter expression in human hepatocellular carcinoma

G Zollner et al.

LIVER INTERNATIONAL (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.